The effect of rapid HIV-1 testing on uptake of perinatal HIV-1 interventions
- 1 January 2003
- journal article
- clinical trial
- Published by Wolters Kluwer Health in AIDS
- Vol. 17 (1) , 113-118
- https://doi.org/10.1097/00002030-200301030-00015
Abstract
We examined whether HIV-1 testing using a rapid assay increases the proportion of pregnant women obtaining HIV-1 results and the uptake of perinatal HIV-1 interventions. Pregnant women attending public health clinics in Nairobi were offered voluntary counselling and testing for HIV-1. Consenting women were randomly assigned to receive either rapid or conventional HIV-1 testing. Women randomly assigned to rapid testing were allowed to receive same-day results or to return later. The results for women randomly assigned to conventional enzyme-linked immunosorbent assay (ELISA) testing were available after 7 days. HIV-1-infected women were referred for antiretroviral prophylaxis to prevent mother-to-child transmission of HIV-1. Among 1282 women offered voluntary HIV-1 testing and counselling, 1249 accepted testing, of whom 627 were randomly assigned to rapid testing and 622 to conventional testing. The median duration between testing and obtaining results was 0 days for women who received rapid testing compared with 11 days for women who received conventional testing. The percentage receiving HIV-1 results was significantly higher among women who received rapid testing compared with conventional testing. Of 161 HIV-1-seropositive women, only 24 received antiretroviral prophylaxis. The uptake of perinatal HIV-1 interventions did not differ between HIV-1-seropositive women randomly assigned to rapid testing or conventional ELISA testing. Rapid HIV-1 testing significantly increased the proportion of women receiving HIV-1 results, which is important for sexual and perinatal HIV-1 prevention. The challenge remains to improve the uptake of perinatal HIV-1 interventions among HIV-1-seropositive women.Keywords
This publication has 12 references indexed in Scilit:
- Efficacy of three short-course regimens of zidovudine and lamivudine in preventing early and late transmission of HIV-1 from mother to child in Tanzania, South Africa, and Uganda (Petra study): a randomised, double-blind, placebo-controlled trialThe Lancet, 2002
- HIV-1 testing in pregnancy: acceptability and correlates of return for test resultsAIDS, 2000
- Prevention of mother-to-child transmission of HIV in developing countries: recommendations for practiceHealth Policy and Planning, 2000
- Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: HIVNET 012 randomised trialThe Lancet, 1999
- Short-course oral zidovudine for prevention of mother-to-child transmission of HIV-1 in Abidjan, Côte d'Ivoire: a randomised trialThe Lancet, 1999
- Short-course zidovudine for perinatal HIV-1 transmission in Bangkok, Thailand: a randomised controlled trialThe Lancet, 1999
- Acceptability of voluntary HIV testing by pregnant women in developing countriesAIDS, 1998
- Attitude of pregnant women towards HIV testing in Abidjan, Côte dʼIvoire and Bobo-Dioulasso, Burkina FasoAIDS, 1998
- Update: HIV counseling and testing using rapid tests--United States, 1995.1998
- On-site HIV testing in resource-poor settingsAIDS, 1997